vs. Teva, Granules & Heritage
Payout Range
Varies
Deadline
7/10/2026
Time Left
51 days
The Teva, Granules & Heritage Metformin NDMA Class Action Settlement involves a $5.55 million fund for individuals who purchased generic metformin manufactured by these companies between July 20, 2015, and June 2, 2020, following a recall due to NDMA contamination concerns.
No specific eligibility requirements listed. Review the official settlement terms for complete criteria.
Individuals in the United States who purchased, paid for, or provided reimbursement for generic versions of metformin-containing drugs manufactured by Teva, Granules, or Heritage between July 20, 2015 and June 2, 2020.
This settlement has the following claim path.
Claimants must provide proof of at least one purchase of metformin.
This settlement accepts online and mail claim submissions. Pick whichever is easier.
Claims Administrator A.B. Data, Ltd. P.O. Box 17300 Milwaukee, WI 53217
ClaimHawk is an independent service. Review the official settlement site for legally binding terms.